Feasibility and acceptability of APOE genotyping in Dutch Brain Research Registry participants
Lisa Waterink, Sven J van der Lee, Daphne Nijland, Leonie NC Visser, Yolande AL Pijnenburg, Sietske AM Sikkes, Wiesje M van der Flier, Marissa D Zwan · 2025
Read Feasibility and acceptability of APOE genotyping in Dutch Brain Research Registry participants by Lisa Waterink, Sven J van der Lee, Daphne Nijland, Leonie NC Visser, Yolande AL Pijnenburg, Sietske AM Sikkes, Wiesje M van der Flier, Marissa D Zwan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715640.txt.
Description
A gene test could pre-screen volunteers for Alzheimer's studies, but only if people accept the test itself. Lisa Waterink and co-authors ran that check in a Dutch brain registry in a 2025 study. Over nine thousand members over fifty, with no reported memory diagnosis, were invited. They were told results would not come back to them. The gene in focus, APOE, shifts the risk of the disease.
Consent ran through a detailed online process with a video. Swab kits then went out by mail for home use. Over three thousand members showed interest at the first step. The team tracked interest, sign-up, and swab return rates to judge feasibility. Surveys also asked how clear the information felt and why people joined.
Catalog record
| CREATOR | Lisa Waterink, Sven J van der Lee, Daphne Nijland, Leonie NC Visser, Yolande AL Pijnenburg, Sietske AM Sikkes, Wiesje M van der Flier, Marissa D Zwan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |